GlaxoSmithKline Agrees to $3B Settlement with U.S.
GlaxoSmithKline PLC has agreed in principle with the U.S. government on a $3 billion settlement of investigations into the company’s sales and marketing practices, the drug maker said Thursday. The agreement is expected to be completed next year, and the …